Literature DB >> 16192649

Peroxide-inducible Ets-1 mediates platelet-derived growth factor receptor-alpha gene transcription in vascular smooth muscle cells.

Michelle R Bonello1, Yuri V Bobryshev, Levon M Khachigian.   

Abstract

Platelet-derived growth factor (PDGF) has been implicated in the pathogenesis of vascular occlusive disorders such as atherosclerosis and restenosis in part due to its regulation of smooth muscle cell phenotype. The molecular mechanisms regulating the expression of PDGF-Ralpha, which binds all known dimeric forms of PDGF except PDGF-DD, are poorly understood. Here we demonstrate that the winged helix-turn-helix proto-oncogene Ets-1 controls PDGF-Ralpha transcription and mRNA expression in smooth muscle cells. Mutational analysis, electrophoretic mobility shift assay, and chromatin immunoprecipitation revealed the existence of a reverse Ets binding motif (-45TTCC-42) in the proximal region of the PDGF-Ralpha promoter, which bound both recombinant and endogenous Ets-1. Ets-1-inducible PDGF-Ralpha expression depended on the integrity of both the -45TTCC-42 motif and the -61G10(-52) element, which resides upstream of -45TTCC-42 and mediates Sp1 induction. Hydrogen peroxide (H2O2) at nanomolar concentrations stimulated levels of Ets-1 and increased PDGF-Ralpha transcription and mRNA expression without affecting Sp1 expression. H2O2 activation of the PDGF-Ralpha promoter was abolished by disrupting -45TTCC-42 or -61G10(-52). These studies identify a functional Ets motif in the PDGF-Ralpha promoter that plays a pivotal role in agonist-inducible PDGF-Ralpha transcription.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16192649      PMCID: PMC1603673          DOI: 10.1016/s0002-9440(10)61203-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

1.  The association of platelet-derived growth factor receptor expression, plaque morphology and histological features with symptoms in carotid atherosclerosis.

Authors:  C D Irvine; S J George; E Sheffield; J L Johnson; A H Davies; P M Lamont
Journal:  Cardiovasc Surg       Date:  2000-03

2.  Differential cooperation between regulatory sequences required for human CD53 gene expression.

Authors:  J Hernández-Torres; M Yunta; P A Lazo
Journal:  J Biol Chem       Date:  2001-07-06       Impact factor: 5.157

3.  PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor.

Authors:  E Bergsten; M Uutela; X Li; K Pietras; A Ostman; C H Heldin; K Alitalo; U Eriksson
Journal:  Nat Cell Biol       Date:  2001-05       Impact factor: 28.824

4.  NF1/X represses PDGF A-chain transcription by interacting with Sp1 and antagonizing Sp1 occupancy of the promoter.

Authors:  Louise A Rafty; Fernando S Santiago; Levon M Khachigian
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

5.  PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor.

Authors:  X Li; A Pontén; K Aase; L Karlsson; A Abramsson; M Uutela; G Bäckström; M Hellström; H Boström; H Li; P Soriano; C Betsholtz; C H Heldin; K Alitalo; A Ostman; U Eriksson
Journal:  Nat Cell Biol       Date:  2000-05       Impact factor: 28.824

Review 6.  High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: a potential role in the pathogenesis of vascular dysfunction in diabetes (review).

Authors:  Ashok K Srivastava
Journal:  Int J Mol Med       Date:  2002-01       Impact factor: 4.101

7.  Chromosomal location, exon structure, and vascular expression patterns of the human PDGFC and PDGFD genes.

Authors:  M Uutela; J Laurén; E Bergsten; X Li; N Horelli-Kuitunen; U Eriksson; K Alitalo
Journal:  Circulation       Date:  2001-05-08       Impact factor: 29.690

8.  Ets-1 positively regulates Fas ligand transcription via cooperative interactions with Sp1.

Authors:  Mary M Kavurma; Yuri Bobryshev; Levon M Khachigian
Journal:  J Biol Chem       Date:  2002-04-22       Impact factor: 5.157

9.  Expressional changes of the vascular antioxidant system in atherosclerotic coronary arteries.

Authors:  Seiichi Kobayashi; Nobutaka Inoue; Hiroshi Azumi; Tadashi Seno; Ken-ichi Hirata; Seinosuke Kawashima; Yoshitake Hayashi; Hiroshi Itoh; Hiroshi Yokozaki; Mitsuhiro Yokoyama
Journal:  J Atheroscler Thromb       Date:  2002       Impact factor: 4.928

10.  Basal transcription of the mouse sarco(endo)plasmic reticulum Ca2+-ATPase type 3 gene in endothelial cells is controlled by Ets-1 and Sp1.

Authors:  Lahouaria Hadri; Anne Ozog; Fabrice Soncin; Anne-Marie Lompré
Journal:  J Biol Chem       Date:  2002-07-15       Impact factor: 5.157

View more
  6 in total

Review 1.  Sp1 phosphorylation and its regulation of gene transcription.

Authors:  Nicole Y Tan; Levon M Khachigian
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

2.  The counter-regulatory effects of ESE-1 during angiotensin II-mediated vascular inflammation and remodeling.

Authors:  Yumei Zhan; Lei Yuan; Maiko Kondo; Peter Oettgen
Journal:  Am J Hypertens       Date:  2010-08-05       Impact factor: 2.689

Review 3.  ROS-induced ROS release in vascular biology: redox-redox signaling.

Authors:  Natalya S Zinkevich; David D Gutterman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-17       Impact factor: 4.733

4.  Injury-induced platelet-derived growth factor receptor-alpha expression mediated by interleukin-1beta (IL-1beta) release and cooperative transactivation by NF-kappaB and ATF-4: IL-1beta facilitates HDAC-1/2 dissociation from promoter.

Authors:  Ning Zhang; Levon M Khachigian
Journal:  J Biol Chem       Date:  2009-07-31       Impact factor: 5.157

Review 5.  Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review.

Authors:  Rokas Navickas; Diane Gal; Aleksandras Laucevičius; Agnė Taparauskaitė; Monika Zdanytė; Paul Holvoet
Journal:  Cardiovasc Res       Date:  2016-06-29       Impact factor: 10.787

6.  Alterations in transcriptional responses associated with vascular aging.

Authors:  Yumei Zhan; Lei Yuan; Peter Oettgen
Journal:  J Inflamm (Lond)       Date:  2009-05-21       Impact factor: 4.981

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.